We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-16.78%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$25.5B
AUM Growth
-$11.1B
Cap. Flow
-$5.25B
Cap. Flow %
-20.57%
Top 10 Hldgs %
6.83%
Holding
3,851
New
730
Increased
952
Reduced
1,216
Closed
943

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.44%
2 Technology 14.21%
3 Industrials 12.1%
4 Healthcare 9.72%
5 Financials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
2801
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$108K ﹤0.01%
91,296
+20,721
+29% +$37.3K
NCMI icon
2802
National CineMedia
NCMI
$385M
$107K ﹤0.01%
1,652
-13,350
-89% -$1.05M
JMEI
2803
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$107K ﹤0.01%
+5,824
New +$119K
EGO icon
2804
Eldorado Gold
EGO
$9.3B
$106K ﹤0.01%
+36,894
New +$131K
ATHX
2805
DELISTED
Athersys, Inc. Common Stock
ATHX
$106K ﹤0.01%
2,948
-2,253
-43% -$108K
DNTH icon
2806
Dianthus Therapeutics
DNTH
$6.03B
$104K ﹤0.01%
+1,145
New +$156K
SN
2807
DELISTED
Sanchez Energy Corporation
SN
$104K ﹤0.01%
+383,986
New +$492K
VHI icon
2808
Valhi
VHI
$399M
$102K ﹤0.01%
4,400
+2,990
+212% +$75.1K
ONCT
2809
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$102K ﹤0.01%
938
+193
+26% +$38.6K
APYX icon
2810
Apyx Medical
APYX
$176M
$101K ﹤0.01%
+15,600
New +$94.5K
AMRS
2811
DELISTED
Amyris Inc.
AMRS
$101K ﹤0.01%
30,231
-424,959
-93% -$2.45M
COTY icon
2812
CALL
Coty
COTY
$2.53B
$100K ﹤0.01%
+15,200
New +$140K
PCTI
2813
DELISTED
PCTEL, Inc. Common Stock
PCTI
$99K ﹤0.01%
23,089
-3,342
-13% -$14.6K
PFIE
2814
DELISTED
Profire Energy, Inc
PFIE
$98K ﹤0.01%
67,520
+11,920
+21% +$27.7K
VER
2815
DELISTED
VEREIT, Inc.
VER
$98K ﹤0.01%
2,743
+80
+3% +$2.97K
CLF icon
2816
Cleveland-Cliffs
CLF
$7.04B
$96K ﹤0.01%
12,452
-889,994
-99% -$8.9M
RRTS
2817
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$95K ﹤0.01%
7,626
+497
+7% +$7.54K
ERIC icon
2818
Ericsson
ERIC
$33.1B
$94K ﹤0.01%
+10,600
New +$92.1K
OPRA
2819
Opera Ltd
OPRA
$1.78B
$94K ﹤0.01%
+16,825
New +$115K
SEAC
2820
DELISTED
Seachange International Inc
SEAC
$94K ﹤0.01%
3,713
-3,673
-50% -$117K
NMR icon
2821
Nomura Holdings
NMR
$29B
$93K ﹤0.01%
25,008
+3,565
+17% +$16K
SPPI
2822
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$91K ﹤0.01%
+10,400
New +$132K
FENG
2823
Phoenix New Media
FENG
$18.3M
$90K ﹤0.01%
4,699
-4,604
-49% -$94.2K
HDSN
2824
Hudson Technologies
HDSN
$260M
$90K ﹤0.01%
101,459
-23,105
-19% -$25.4K
RBBN icon
2825
Ribbon Communications
RBBN
$370M
$87K ﹤0.01%
18,003
-26,167
-59% -$152K

Similar funds

Two Sigma Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Two Sigma Investments held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Two Sigma Investments withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Two Sigma Investments opened a new position in Starbucks worth $176M.

  • Two Sigma Investments's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
  • Two Sigma Investments added most to SLB Ltd in Q4 2018, an estimated $230M increase.
  • Two Sigma Investments's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
  • Two Sigma Investments fully exited Elevance Health in Q4 2018, selling an estimated $180M.
  • Two Sigma Investments's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
  • Two Sigma Investments opened 730 new positions and closed 943 in Q4 2018.
  • Two Sigma Investments's portfolio value fell 30% quarter-over-quarter to $25.5B.

Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.